Morningside Group Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 12

Professionals

  • Investments
  • 447

  • Portfolio
  • 167

  • Exits
  • 154

Exits

Morningside Group General Information

Company Description

Founded in 1986, Morningside Group is a venture capital firm based in Newton, Massachusetts. The firm makes venture capital investments in companies with novel science and technology. The firm is characterized by a long-term outlook in company-building and an unwavering commitment to acting ethically. The firm's team of entrepreneurial investment professionals has experience in life sciences, digital health, AI, materials, and technology. The firm's charitable commitments to education, research, and healthcare include the Harvard T.H. Chan School of Public Health, the UMass Chan Medical School, and the MIT Morningside Academy for Design.

Business Details

Year Founded
1986
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Family Office
Growth/Expansion
Corporate Office
  • 1188 Centre Street
  • Newton Centre
  • Newton, MA 02459-0000
  • United States
+1 (617)

Morningside Group Investments & Acquisitions (447)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Synphatec 28-Sep-2026 Early Stage VC Drug Discovery Generating Revenue
AdvanCell 15-Jul-2026 Drug Discovery Clinical Trials - Phase 2
Mighty Therapeutics 14-Jul-2026 Drug Discovery Generating Revenue
Dermatic Health 12-Jun-2026 Decision/Risk Analysis Startup
Ampa Health 14-May-2026 Therapeutic Devices Generating Revenue
Valitor (Biotechnology) 05-May-2026 Biotechnology Pre-Clinical Trials
SimpliFed 07-Apr-2026 Clinics/Outpatient Services Generating Revenue
3X Genetics 25-Mar-2026 Diagnostic Equipment Generating Revenue
Cognito Therapeutics 05-Mar-2026 Later Stage VC Therapeutic Devices Clinical Trials - Phase 3
Angitia Biopharmaceuticals 27-Jan-2026 Later Stage VC Drug Discovery Clinical Trials - Phase 3
You’re viewing 10 of 447 investments and acquisitions. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Morningside Group Exits (154)

Company Name Exit Date Exit Type Exit Size
Ground Signal 13-Oct-2026 Buyout/LBO
Stavvy 06-Oct-2026
Evonetix 08-Sep-2026
Apnimed 31-Jul-2026
ViOptix 15-Jul-2026
Alebund Pharmaceuticals 29-Jun-2026
Pinteon Therapeutics 29-Apr-2026
Adjuvance 25-Apr-2026
Alamar Biosciences 16-Apr-2026 IPO
EpiVax Therapeutics 02-Apr-2026 Out of Business
You’re viewing 10 of 154 exits. Get the full list »

Morningside Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Morningside Group Co-Investors (307)

Name With Exits Lead Partner Series Industry
5Y Capital 5 Series chart Industry bar
Alumni Ventures Series chart Industry bar
OrbiMed Series chart Industry bar
Forbion Series chart Industry bar
T. Rowe Price Group Series chart Industry bar
You’re viewing 5 of 307 co-investors. Get the full list »

Morningside Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
5Y Capital Shanghai, China 2008

Morningside Group FAQs

  • What is Morningside Group?

    Founded in 1986, Morningside Group is a venture capital firm based in Newton, Massachusetts.

  • When was Morningside Group founded?

    Morningside Group was founded in 1986.

  • Where is Morningside Group headquartered?

    Morningside Group is headquartered in Newton, MA.

  • How many investments has Morningside Group made?

    Morningside Group has made 447 investments.

  • What has Morningside Group invested in?

    Morningside Group has made numerous investments in companies like Synphatec, AdvanCell, and Mighty Therapeutics within the Drug Discovery industry.

  • What has Morningside Group invested in recently?

    Morningside Group's latest investment was on 28-Sep-2026 in Synphatec, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process